S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Evelo Biosciences (EVLO) Insider Trading & Ownership

$0.05
0.00 (0.00%)
(As of 10:14 AM ET)

Evelo Biosciences (NASDAQ:EVLO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.02%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$12.50 M
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$78,917.36
Get EVLO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Evelo Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

EVLO Insider Buying and Selling by Quarter


Evelo Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/8/2023Marella ThorellCFOSell1,811$0.33$597.63  
11/8/2023Mark BodmerInsiderSell3,163$0.33$1,043.79  
11/8/2023Simba GillCEOSell172$0.33$56.76  
9/28/2023Simba GillCEOSell1,996$3.94$7,864.24  
8/8/2023Marella ThorellCFOSell2,004$9.51$19,058.04  
8/8/2023Mark BodmerInsiderSell3,128$9.51$29,747.28  
8/8/2023Simba GillCEOSell342$9.51$3,252.42  
7/11/2023Ventures Fund Iv Gene FlagshipMajor ShareholderBuy5,411,255$2.31$12,499,999.05  
5/23/2023Mark BodmerInsiderSell1,128$2.80$3,158.40  
5/8/2023Duncan MchaleInsiderSell3,336$2.60$8,673.60  
5/8/2023Marella ThorellCFOSell1,926$2.60$5,007.60  
5/8/2023Simba GillCEOSell176$2.60$457.60  
(Data available from 1/1/2013 forward)












EVLO Insider Trading Activity - Frequently Asked Questions

Who is on Evelo Biosciences's Insider Roster?

The list of insiders at Evelo Biosciences includes Duncan Mchale, Marella Thorell, Mark Bodmer, Simba Gill, Stephen J Carriere, and Ventures Fund Iv Gene Flagship. Learn more on insiders at EVLO.

What percentage of Evelo Biosciences stock is owned by insiders?

1.02% of Evelo Biosciences stock is owned by insiders. Learn more on EVLO's insider holdings.

Which Evelo Biosciences insiders have been buying company stock?

The following insider purchased EVLO shares in the last 24 months: Ventures Fund Iv Gene Flagship ($52,499,969.45).

How much insider buying is happening at Evelo Biosciences?

Insiders have purchased a total of 6,781,117 EVLO shares in the last 24 months for a total of $52,499,969.45 bought.

Which Evelo Biosciences insiders have been selling company stock?

The following insiders have sold EVLO shares in the last 24 months: Duncan Mchale ($8,673.60), Marella Thorell ($24,663.27), Mark Bodmer ($33,949.47), Simba Gill ($11,631.02), and Stephen J Carriere ($148.40).

How much insider selling is happening at Evelo Biosciences?

Insiders have sold a total of 19,189 Evelo Biosciences shares in the last 24 months for a total of $79,065.76 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:EVLO) was last updated on 2/23/2024 by MarketBeat.com Staff